Skip to content

EVALUATION OF INDIVIDUALIZED HOMOEOPATHIC TREATMENT FOR URINARY INCONTINENCE IN POST MENOPAUSAL WOMEN

A STUDY TO EVALUATE THE EFFICACY OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN URINARY INCONTINENCE AMONG POST MENOPAUSAL WOMEN USING REVISED URINARY INCONTINENCE SCALE (RUIS) - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099199
Enrollment
65
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N394- Other specified urinary incontinence

Interventions

Intervention1: Individualized Homoeopathic Medicine: The intervention involves the administration of an individualized homoeopathic remedy, to post menopausal women suffering from urinary incontinence
one dose in 30th potency as per requirement of the case. The treatment aims to reduce the frequency, intensity of urinary incontinence, as measured by the RUIS (Revised Urinary Incontinence Scale). Th

Sponsors

Dr Indrajit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All Post menopausal females of mild & moderate urinary incontinence according to 3 I Q (3 question questionnaire for diagnosis) will be included. 2.Cases will be included on the basis of history & physical examination. 3.Patients will be screened by USG & urine routine

Exclusion criteria

Exclusion criteria: .Patients with Overflow urinary incontinence 2.Patients with Neurological Dysfunction like Multiple Sclerosis, Schizophrenia, spinal cord injury 3.Patients with Genitourinary Fistula. 4.Patients with Cardiac Pathology e.g.: Congestive Heart Failure, Ischemic heart disease, Cardiomyopathy. 5.Patients suffering with respiratory conditions that cause chronic coughing like COPD, Asthma

Design outcomes

Primary

MeasureTime frame
Reduction in the baseline score on RUIS scale after giving individualized homoeopathic medicinesTimepoint: Baseline (Day 0) and Last Follow up (Day 180)

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Jyothi Vijaykumar

AM Shaikh Homoeopathic Medical College And Hospital Belgaum

Jyothivijaykumar3@yahoo.co.in9964357653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026